Darwin Knows

Paradigm Biopharmaceuticals Ltd

Darwin Score	+18
Ticker	PAR
Latest Price	0.47 AUD as of close on 04-Jul-2025
3 Month price range	0.28 to 0.46 AUD
Market Capitalisation	171.35Mn AUD
Country	Australia
Region	Asia
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. See More ...
Company URL	https://www.paradigmbiopharma.com

See Darwins Full Analysis for Paradigm Biopharmaceuticals Ltd

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Paradigm Biopharmaceuticals Ltd. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+27
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	-3
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	-6

Alerts

There are 7 live alerts for Paradigm Biopharmaceuticals Ltd.

Volume is 2.2x 20 day average. Significant move up of +18.2%. (Positive)
Overbought - The 15 day RSI is +82.3. (Negative)
Overbought - The 30 day RSI is +73.6. (Negative)
Overbought - The 5 month RSI is +72.9. (Negative)
The 20d moving average turned upwards 3 days ago. (Positive)
The 50d moving average turned upwards 3 days ago. (Positive)
The 377d moving average turned upwards yesterday. (Positive)

Peer Comparison

There are 12 peers of Paradigm Biopharmaceuticals Ltd.
Asset Name Industry Group Perf(20d)% Asset Score
Argenica Therapeutics Ltd (AGN) Biotechnology -2.0 +22
Arovella Therapeutics Ltd (ALA) Biotechnology +19.2 +2
CSL Ltd (CSL) Biotechnology -2.1 +19
Clinuvel Pharmaceuticals Ltd (CUV) Biotechnology -1.9 +7
Imugene Ltd (IMU) Biotechnology -23.7 -9
Mesoblast Ltd (MSB) Biotechnology -7.9 -10
Opthea Ltd (OPT) Biotechnology 0 -12
PYC Therapeutics Ltd (PYC) Biotechnology +9.1 +24
Polynovo Ltd (PNV) Biotechnology -9.1 +2
Race Oncology Ltd (RAC) Biotechnology -0.4 -9
Telix Pharmaceuticals Ltd (TLX) Biotechnology -11.9 +7
Tissue Repair Ltd (TRP) Biotechnology +16.2 -10

Asset Name	Industry Group	Perf(20d)%	Asset Score
Argenica Therapeutics Ltd (AGN)	Biotechnology	-2.0	+22
Arovella Therapeutics Ltd (ALA)	Biotechnology	+19.2	+2
CSL Ltd (CSL)	Biotechnology	-2.1	+19
Clinuvel Pharmaceuticals Ltd (CUV)	Biotechnology	-1.9	+7
Imugene Ltd (IMU)	Biotechnology	-23.7	-9
Mesoblast Ltd (MSB)	Biotechnology	-7.9	-10
Opthea Ltd (OPT)	Biotechnology	0	-12
PYC Therapeutics Ltd (PYC)	Biotechnology	+9.1	+24
Polynovo Ltd (PNV)	Biotechnology	-9.1	+2
Race Oncology Ltd (RAC)	Biotechnology	-0.4	-9
Telix Pharmaceuticals Ltd (TLX)	Biotechnology	-11.9	+7
Tissue Repair Ltd (TRP)	Biotechnology	+16.2	-10

To see complete information on Paradigm Biopharmaceuticals Ltd or any other assets please login.

If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.